Amgen to close Bothell, Seattle facilities

BOTHELL — Despite “robust growth,” Amgen, one of the world’s biggest pharmaceutical companies, is shutting down operations in Bothell and Seattle, which means the loss of several hundred jobs in Washington.

The company also plans to pull out of Colorado and reduce its headquarters workforce, while expanding in biotechnology hubs in San Francisco and Cambridge, Massachusetts. The moves are expected to trim operating costs, Amgen CEO Robert Bradway told investors and stock analysts on Tuesday.

In all, the company plans to cut 2,400 to 2,900 jobs — about 12 to 15 percent of its global workforce — by the end of 2015.

Bradway praised workers at the locations to be closed, saying they “have made enormous contributions to advancing biotechnology over the years and the surrounding communities have been very supportive, so it is with great reluctance that we acknowledge the need to exit.”

Amgen, which is based in Thousand Oaks, California, is talking with “third-parties about potential use of the facilities,” he said.

The changes will shrink Amgen’s physical presence by 23 percent, and reduce operating costs by about $700 million by 2016 as compared to 2013. The savings will be used to support new product launches, according to a news release from the company.

Amgen is also considering other steps to increase efficiency and trim costs, according to the release.

The company did not immediately respond to requests for comment.

The Bothell facility has fewer than 100 workers, according to news reports.

The company has about 660 research staff in Washington and 200 in Colorado, according to FierceBiotech, a news website that covers the biotechnology industry.

Despite the closures, Amgen’s revenue increased 11 percent in the second quarter of the year, as did its earnings per share, which saw a 25 percent jump to $2.37.

“From a position of strength, we have announced today restructuring initiatives that will allow us to reallocate resources to invest in our upcoming launches and drive growth,” Bradway said in the release.

Dan Catchpole: 425-339-3454; dcatchpole@heraldnet.com; Twitter: @dcatchpole.

More in Herald Business Journal

Best foot forward: Ferndale company to make custom shoes easy

Long specializing in insoles, Superfeet is putting 3-D machines in stores to make customized shoes.

Port of Everett CEO Les Reardanz has been called up and will be spending much of the year away from his office. He is going to Afghanistan. (Dan Bates / The Herald)
Port of Everett CEO reporting for duty — in Afghanistan

Les Reardanz has been called to active duty with the Navy for an eight-month deployment.

Alaska Airlines to announce Paine Field destinations Tuesday

The Snohomish County airport’s passenger terminal is slated to see flights this fall.

Early boarding pass: Everett’s rising passenger terminal

Here’s what to expect when two airlines begin passenger service at Paine Field later this year.

Closing of 63 Sam’s Club stores impacts small business

The retailer has historically prided itself on the services it has provided small business members.

Ford goes ‘all in’ on electric cars with $11 billion investment

That’s up from the $4.5 billion that Ford said in late 2015 it would invest through the end of the decade.

New pickups from Ram, Chevy heat up big-truck competition

Big pickup truck sales are important to automakers, which make huge profits on them.

Intel underfoot: Floor sensors rise as retail data source

The sensors can also be used in office buildings to reduce energy costs and nursing homes for falls.

Most Read